Perceptive Advisors

Latest statistics and disclosures from Perceptive Advisors's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are INFI, Aegerion Pharmaceuticals, Sarepta Therapeutics, NBIX, Acelrx Pharmaceuticals. These five stock positions account for 58.69% of Perceptive Advisors's total stock portfolio.
  • Added to shares of Neptune Technologies Bioreso (+$5.04M).
  • As of March 31, 2013, Perceptive Advisors has $837.27M in assets under management (AUM). Assets under management grew from a total value of $832.23M to $837.27M.
  • Independent of market fluctuations, Perceptive Advisors was a net buyer by $5.04M worth of stocks in the most recent quarter.

Perceptive Advisors portfolio companies for quarter ending March 2013

Ticker Name Portfolio Weight Change Share Count Price Last Trade
INFI Infinity Pharmaceuticals 18.81 3249255 48.47 25.35
Aegerion Pharmaceuticals 17.22 3573426 40.34 0.00
Sarepta Therapeutics 13.18 2986600 36.96 0.00
NBIX Neurocrine Biosciences 6.39 4402637 12.15 11.88
Acelrx Pharmaceuticals 3.09 5008400 5.16 0.00
CSU Capital Senior Living Corporation 2.66 843500 26.43 26.03
EXAS EXACT Sciences Corporation 2.53 2159408 9.80 10.70
SHPGY Shire 2.30 210800 91.36 0.00
VPHM ViroPharma Incorporated 2.27 756300 25.16 25.88
CELG Celgene Corporation 2.15 155000 115.92 124.00
QCOR Questcor Pharmaceuticals 2.12 546000 32.54 37.26
HCA HOLDINGS 1.84 380000 40.63 0.00
Neptune Technologies Bioreso 1.66 +56.00% 5522920 2.52 0.00
Repros Therapeutics 1.64 852650 16.10 0.00
GILD Gilead Sciences 1.61 276200 48.94 56.07
REGN Regeneron Pharmaceuticals 1.37 65000 176.40 257.57
CHTP Chelsea Therapeutics International 1.37 5630000 2.04 1.85
VRTX Vertex Pharmaceuticals Incorporated 1.31 200000 54.97 79.49
Covidien 1.27 156500 67.84 0.00
SNTA Synta Pharmaceuticals 1.12 1093236 8.60 7.45
Astex Pharmaceuticals 1.12 2092855 4.47 0.00
CPTS Conceptus 1.04 361733 24.15 30.95
NVS Novartis AG 0.89 104300 71.24 74.21
ATHX Athersys 0.89 4456797 1.68 1.93
BIIB Biogen Idec 0.86 37500 192.61 230.76
PBTH PROLOR Biotech 0.84 1391243 5.06 6.44
LXRX Lexicon Pharmaceuticals 0.83 3199500 2.18 2.12
ISIS ISIS Pharmaceuticals 0.61 300000 16.94 20.41
CUTR Cutera 0.59 377350 13.00 9.11
Tesaro 0.52 197900 21.96 0.00
ALNY Alnylam Pharmaceuticals 0.46 157000 24.37 27.89
Newlink Genetics Corporation 0.44 300000 12.27 0.00
Dyax 0.39 751457 4.36 0.00
Supernus Pharmaceuticals 0.39 582829 5.62 0.00
NPSP NPS Pharmaceuticals 0.37 302400 10.21 14.35
Cempra 0.36 450000 6.75 0.00
ITMN InterMune 0.32 300000 9.05 10.00
Anthera Pharmaceuticals 0.27 3451655 0.66 0.00
NBS Neostem 0.27 3315938 0.68 0.57
IMMU Immunomedics 0.21 739144 2.41 3.04
CLSN Celsion Corporation 0.21 1706500 1.05 0.93
INC Ventrus Biosciences 0.20 560000 2.99 0.00
TKM Tekmira Pharmaceuticals Corporation 0.18 320000 4.74 0.00
BMR BioMed Realty Trust 0.16 63000 21.60 22.91
Alkermes 0.14 50000 23.70 0.00
VVUS VIVUS 0.13 100000 11.00 12.30
Champions Oncology 0.13 1808244 0.60 0.00
XOMA CORP Common equity shares 0.12 292250 3.49 0.00
Mgc Diagnostics 0.12 139264 6.99 0.00
HTWR HeartWare International 0.11 10000 88.40 96.01
MDVN Medivation 0.10 17500 46.74 47.61
ACHN Achillion Pharmaceuticals 0.10 100000 8.75 7.70
TBIO Transgenomic 0.10 2000000 0.40 0.49
UPI Uroplasty 0.09 287613 2.49 2.11
Medgenics 0.09 150000 4.85 0.00
RIGL Rigel Pharmaceuticals 0.08 100000 6.80 4.60
Liposcience 0.08 65129 10.52 0.00
CLDX Celldex Therapeutics 0.07 50000 11.58 12.59
INSTRS INC Stemcells 0.05 231600 1.73 0.00
Sunesis Pharmaceuticals 0.04 58010 5.46 0.00
MYGN Myriad Genetics 0.03 10000 25.40 33.34
ESC Emeritus Corporation 0.03 10000 27.80 25.60
ZIOP ZIOPHARM Oncology 0.02 100000 1.83 1.67
RTIX RTI Biologics 0.01 27312 3.92 4.35
Neoprobe 0.01 20000 2.70 0.00
Combimatrix Corporation *w exp 05/01/ 0.00 5000 0.40 0.00

Past 13F-HR SEC Filings for Perceptive Advisors

View All Filings for Perceptive Advisors